Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,627,527
  • Shares Outstanding, K 32,780
  • Annual Sales, $ 490,640 K
  • Annual Income, $ 81,680 K
  • 36-Month Beta 2.26
  • Price/Sales 3.32
  • Price/Cash Flow 13.98
  • Price/Book 3.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.80 +11.16%
on 11/14/17
50.40 -1.19%
on 11/22/17
+3.45 (+7.44%)
since 11/10/17
3-Month
42.55 +17.04%
on 11/06/17
57.30 -13.09%
on 10/05/17
-1.25 (-2.45%)
since 09/12/17
52-Week
42.55 +17.04%
on 11/06/17
62.95 -20.89%
on 05/04/17
-3.60 (-6.74%)
since 12/12/16

Most Recent Stories

More News
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) ("Peregrine") and Ronin Trading, LLC and SW Investment Management LLC (together, "Ronin/SWIM"), collectively Peregrine's largest stockholder,...

PPHM : 4.24 (-20.75%)
PPHMP : 24.51 (-2.82%)
TMO : 189.04 (-0.24%)
MRK : 56.82 (+0.85%)
CBM : 49.80 (+0.30%)
Corporate News Blog - Puma Biotechnology's 5-Year Analysis of Phase-III ExteNET Study Gets Published in â??The Lancet Oncology'

Research Desk Line-up: Cambrex Post Earnings Coverage

PBYI : 101.10 (-0.05%)
CBM : 49.80 (+0.30%)
Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed an expansion of cGMP small...

CBM : 49.80 (+0.30%)
Cambrex Reports Third Quarter 2017 Financial Results

- Net Revenue increased 13% and EBITDA increased 29% vs. prior year quarter -

CBM : 49.80 (+0.30%)
Cambrex Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Cambrex Corporation (NYSE: CBM) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 8:30 AM Eastern Time....

CBM : 49.80 (+0.30%)
Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Gregory B. Brown, M.D. was appointed to the...

CLBS : 3.53 (-1.40%)
CBM : 49.80 (+0.30%)
Cambrex to Announce Third Quarter 2017 Financial Results on November 7, 2017

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that third quarter 2017 financial results will be...

CBM : 49.80 (+0.30%)
Cambrex Becomes Oversold (CBM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

CBM : 49.80 (+0.30%)
Cambrex Adds Large Scale Manufacturing Capacity at Its Charles City, Iowa Facility

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced the completion of an expansion to its large scale...

CBM : 49.80 (+0.30%)
Cambrex Invests in Generic API Development and Manufacturing Capabilities at Its Milan Site

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has made a number of investments, in both...

CBM : 49.80 (+0.30%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

2nd Resistance Point 50.25
1st Resistance Point 49.95
Last Price 49.80
1st Support Level 49.30
2nd Support Level 48.95

See More

52-Week High 62.95
Fibonacci 61.8% 55.16
Fibonacci 50% 52.75
Fibonacci 38.2% 50.34
Last Price 49.80
52-Week Low 42.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.